Published today in @CRC_AACR: research from CU Cancer Center's Bradley Corr, MD, and Benjamin Bitler (@bitlerlabucd), PhD, shows a first-of-its-kind combination therapy that could make treatment for hard-to-treat ovarian cancer more effective ⬇️
https://t.co/LrRt9gfpL5
Today on #GivingTuesday, your gift can make 2x the difference for the ovarian & gynecologic cancer community, with every dollar matched by a generous donor: https://t.co/aCqkOhv4Fo. We are grateful to all who are helping to push progress forward. 🩵💜
We are sending our deepest condolences to the family and friends of CU Cancer Center's Joshua Black, PhD, who passed away last month at the age of 45, following a battle with cancer. We encourage contributions at https://t.co/0OzrfoOtgL for a research lectureship in his honor.
We remember and honor Joshua Black, PhD, who passed away on Oct. 25, 2025. Josh was a brilliant scientist, a beloved colleague, and a cherished friend whose life was cut far too short.
To honor his legacy and support a research lectureship in his honor, we invite you to contribute in his memory at https://t.co/vNDiN3w4Z7.
If you would like to make your gift by mail, please make your check out to the University of Colorado Foundation in support of CU Anschutz Fund for Excellence in memory of Josh Black.
University of Colorado Foundation
P.O. Box 17126
Denver, CO 80217-9155
Toni Moses, RN, a @uchealth emergency department nurse, is grateful for CU Cancer Center member Bradley Corr, MD, who led the clinical trial she took part in to combat her ovarian cancer ⬇️
https://t.co/LOUkZAqap4
#OvarianCancerAwarenessMonth: International research by CU Cancer Center member Lindsay Brubaker, MD, aims to transform ovarian cancer treatment by finding ways to optimize precision medicines for more patients ⬇️
https://t.co/RvfYFA9Xwm
Congrats to Valerie, our @CUCancerCenter CREU student, for finishing her summer research experience! She spent the summer investigating macrophage differentiation and ovarian cancer.
A phase II, randomized, double-blind study of the use of rucaparib vs.... https://t.co/yPZYXP3Eqd
A 20-month PFS benefit with a PARP inhibitor against recurrent endometrial cancer! @CUCancerCenter
Schroeder breast cancer lab in Arizona starts crowdfunding campaign. A PhD student in my PhD lab started fundraising to continue her breast cancer research! #determination#sciencerules https://t.co/Crb9WJG6qp
University of Colorado Ovarian Cancer Innovations Group website is live!! Check it out!
https://t.co/i0c7Dmw7ys
@CUGynOnc@ronny_drapkin@airdlab @SikoraLab @DiFeoLab